Despite the increased attention paid to patient safety over the past 15 years since the publication of "To Err Is Human," harm rates for hospitalized patients remain high. 1, 2 Advanced harm detection techniques suggest that national rates of harm resulting in death among hospitalized patients are .4 times higher than originally reported. These rates suggest that almost half a million people die in the United States per year as a result of hospital-associated harm. 3 This estimate would place patient harm as the third leading overall cause of death behind heart disease and cancer. 4 Consistent and accurate detection of patient harm remains a challenge for most organizations. Although voluntary reports have been shown to capture only 2% to 8% of all harms, they remain the mainstay of harm detection in most hospitals. 5 The Institute of Healthcare Improvement (IHI) noted recently that "public health researchers have established that only 10 to 20 percent of errors are ever reported and, of those, 90 to 95 percent cause no harm to patients." 6 Noting this gap, efforts to improve harm detection have accelerated, with the most visible perhaps being the development, testing, and dissemination of the adult-focused IHI Global Trigger Tool (GTT). A "trigger" is a medical recordbased "hint" (such as the use of the antidote naloxone) that "triggers" the search of the medical record to determine whether an adverse event (such as a clinical overdose of an opiate, as opposed to a therapeutic use in response to a nonprescribed opiate use) might have occurred. The GTT, which includes 55 such triggers, has been used in such settings as the North Carolina Patient Safety Study, the Office of the Inspector General of the Centers for Medicare and Medicaid Services report on inpatient harm, and the Office of the Inspector General work in skilled nursing facilities. 2, [6] [7] [8] [9] [10] [11] These efforts have reinforced the perspective that the trigger tool approach is at present the most reliable and consistent harm detection method. 3, 7, 10 Although the IHI GTT was designed for the adult population, 1 children's hospital tested it on its pediatric inpatient records and identified [13] [14] [15] [16] [17] However, a single, pediatric-specific detection tool that can be applied across all settings, analogous to the IHI's GTT, has not been available. Until a comprehensive standard harm measure is established in pediatrics, improvement efforts will continue to focus on a fraction of the harm that occurs to patients, leaving countless harms within the system unrecognized and unaddressed. 18 Recently, a comprehensive pediatric trigger list for the inpatient environment using a modified Delphi technique was developed.
The tool was modeled after the IHI GTT and named the Pediatric AllCause Harm Measurement Tool (PACHMT). 19 Of note, the PACHMT was developed anticipating future automation to allow integration into electronic health records. Using the PACHMT, we sought to pilot test the tool to estimate harm rates across 6 children's hospitals and to ensure the feasibility and appropriateness of the tool as a way to estimate the rates of all-cause harm in hospitalized children. Although no tool can consistently identify all causes of harm, the PACHMT was designed to identify many of the most common causes of pediatric harm able to be recognized through trigger methodology.
METHODS

Design, Setting, and Patients
As has been done in previous trigger tool studies, we used a cross-sectional study design, using retrospective chart review in 6 academic freestanding children's hospitals with previous trigger tool experience from different regions of the country. Patient records were eligible for inpatients who were ,22 years of age, had a length of stay between 24 hours and 6 months, and were discharged in February 2012. 20 Any patients who were admitted for rehabilitation, to the normal newborn nursery, to day treatment areas, or with a primary discharge diagnosis related to psychiatric or obstetric care were excluded as is consistent with earlier study designs. [12] [13] [14] [15] [16] [17] A random sample of 100 patients who met the inclusion criteria was selected from each site for review. Institutional review board waiver or approval for this study was granted at each site.
Intervention
The list of pediatric-specific triggers from the PACHMT was created via a modified Delphi process described previously. 19 The PACHMT trigger list ( The reviewer-physician team at each site then applied the standard trigger tool review method to review their 100 charts. There were no limits placed on the review time per chart. Once a trigger was identified, the reviewer would determine if there was harm. Harm was defined as an "unintended physical injury (resulting from or contributed to) by medical After the reviewer's assessment of a chart and PACHMT trigger application, physician reviewers reviewed a summary of the harm and either confirmed or modified the primary reviewer's assessment. The physician reviewer's assessment and scoring of the case was considered final.
Outcomes
The primary outcomes of this study were harms per patient and harms per 1000 patient days. Secondary outcomes of interest were (1) triggers per patient,(2) trigger-positive predictive values (defined as the number of times a specific trigger independently identified harm divided by the number of times a trigger was identified) individually and for PACHMT in total,(3) harm severity,(4) percentage of harms that were preventable, percentage of harms that were also identified in local occurrence reports, and median time for chart review.
Statistical Analysis
Patient characteristics were described with means and 95% confidence intervals (CIs), as well as medians with interquartile ranges (IQRs). We summarized harms with frequencies and percentages, and computed rates with 95% Poisson CIs. Finally, for each trigger, we report positive predictive values with exact binomial 95% confidence intervals (CI). All analyses were performed with SAS v.9.3 (SAS, Cary, NC), and P , .05 were considered statistically significant.
RESULTS
The median age of patients whose chart was in the study was 4 years (IQR: 0.5-12.0), and 287 (47.8%) were female. The median length of stay was 4 days (IQR: 3-7), and 2.7% of patients had a length of stay .30 days (Table 3 ). "Other" includes the following: diarrhea (n = 3); hyperthermia/fever (n = 3); intubation complications/postextubation stridor (n = 3); cardiac arrest (n = 2); decubitus ulcers (n = 2); dehydration (n = 2); gastrointestinal bleed (n = 2); insulin use complication or misuse (n = 2); iatrogenic renal injury, renal failure, renal dysfunction (n = 2); other (n = 2); death (n = 1); seizures (n = 1); and weakness/loss of strength (n = 1). The mean time for chart review was 42 minutes with a median of 30 minutes (IQR: 15.5-60.0). Of the 240 harms identified, 22 (9.2%) of these were also identified within the hospital's voluntary reporting system.
The most common harms were intravenous catheter infiltrations/ burns, respiratory distress, constipation, pain, surgical complications and skin rash, bruising, or burn. A complete listing of the harms experienced is included in Table 4 . Sixty-eight percent of the harms documented were rated as level E on the National Coordination Council for Medication Error Reporting and Prevention harm scale. Table 5 categorizes the identified harms by severity level and preventability as determined by the reviewers.
Thirty-six (70.6%) of the PACHMT triggers were identified at least once during the chart review. Table 6 lists the triggers in order of frequency and lists each trigger's positive predictive value.
DISCUSSION
Using a novel pediatric-specific list of triggers, we found 40 harms per 100 admissions among children hospitalized at 6 large children's hospitals. Consistent with earlier trigger-based harm detection studies, nearly one half of the harm was deemed preventable. 2, 13, 14 One of every 4 pediatric admissions in our study had at least 1 identified harm. Our detected harm rate is similar to a recent single-site study, which detected a pediatric harm rate of 37 harm events for every 100 admissions using the adultfocused IHI GTT. 12 This is the first multisite study describing all-cause inpatient pediatric harm using a novel pediatric-specific global trigger tool.
Consistent with previous trigger tool efforts, harms were identified substantially more frequently with the PACHMT than with voluntary reporting. Nevertheless, we consider The following triggers were not identified during chart review: total bilirubin .25 mg/dL; Anti Xa .1.5; Warfarin triggers: international normalized ratio .6; Warfarin triggers: vitamin k administration after warfarin, flumazenil administration, Digibind administration; elevated drug levels (antiepileptics): phenytoin (.30 mcg/mL); elevated drug levels (antiepileptics): valproic acid (.170 mcg/mL); elevated drug levels (antiepileptics): carbamazepine (.20 mcg/mL); elevated drug levels (antiepileptics): oxcarbazepine (.45 mcg/mL); elevated drug levels (antibiotics): gentamicin (trough .4 mcg/mL); elevated drug levels (antibiotics): amikacin (trough .20 mcg/mL); infiltrations: hyaluronidase administration; infiltrations: phentolamine administration; unanticipated insertion of arterial or central venous line during surgery. a One minute or more of sustained saturation ,75% or .2 spot check saturations ,75% in a 24-h period.
these 2 approaches to patient safety measurement to be complementary. Although a trigger tool's systematic measurement captures substantially more harm events, voluntary reporting often provides information related to near miss events that are not detected by the trigger tool methodology. We believe a combination of both approaches results in an enhanced understanding of a system's potential fallibilities. 23 There are several limitations to this study. First, as a pilot, our study had a relatively small sample size and only 1 physician reviewer (rather than the more typical design of 2 physician reviewers) to assess and rate the harms. Second, like adult trigger tool studies, 6, 19 our study lacked definitive evidence for which triggers were the best to include, and it does not capture all harms. In an effort to construct a parsimonious list of highly predictive triggers, several potential triggers such as hypocalcemia or hypokalemia were not included in the final trigger tool. Third, we did not undertake inter-or intrarater reliability testing, so we do not yet know the reliability and consistency of this tool between alternative users. Finally, although this was a relatively large, multicenter pilot study, larger studies are needed to better identify rare but clinically important harms, to define the operating characteristics of less common triggers, and to examine how trigger tools work in a more diverse set of hospitals. The federal Pediatric Quality Measures Program is developing such a measure at present, drawing on the work of PACHMT and other trigger tools.
CONCLUSIONS
The application of a novel pediatric global trigger tool identified 40 harms per 100 admissions in 6 freestanding children's hospitals. Despite more than a decade of intense focus, harm continues to occur in large numbers in hospitalized children. The use of the PACHMT trigger tool will provide the foundation to capture harms in a rigorous and systematic way. Use of such trigger tools will lead to a better understanding of the epidemiology of harm in hospitalized children as well as allow tracking of change with patient-safety-focused interventions. Because this work was only intended to be a pilot study, future research should focus on editing the PACHMT to establish the next generation pediatric global trigger tool, conduct a formal study to establish harm rates and epidemiology, and determine the operating characteristics of this tool, with an eye toward integration into the electronic medical record and eventual automation.
